In Europe, a Medical Device Accelerator Takes Root

Device giant Medtronic and venture capital leader Sofinnova have teamed up to see if they can help seed the promising ground of device start-ups in Europe, providing an outlet for novel ideas of the continent's physicians.

One of Europe's leading venture capital firms, Paris-based Sofinnova Partners, and device-industry powerhouse Medtronic PLC have announced plans to launch a new medical device incubator or accelerator in Europe—born out of what executives at both companies see as a fundamental disconnect between the clinical and technological richness of Europe and the practical reality of starting a company there. The new organization, designed to take advantage of what both companies believe is a wealth of untapped potential for new device ideas from European physicians, is located on the campus of the Ecole Polytechnique Federal Institute of Lausanne (EPFL), one of the leading technical institutes in Europe.

"If you look at the top 100 products that we sell at Medtronic--coronary stents or angioplasty, artificial disks or cardiac...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

EU Digital Omnibus Meets MDR And IVDR Revisions: Alignment Or Chaos?

 

Simultaneous revisions of the EU’s AI, data and medtech rules offer opportunities for simplification and alignment but also risk confusion and competing priorities. With political tensions in the background, does all this portend further unwanted compromises or delays for medtech?

Long-Awaited EUDAMED Notice Ushers In New Era Of Compliance

 

After years of delays - and even skepticism in Rome last month when officials hinted at its imminent debut - the long-awaited EUDAMED medical device database release has finally been confirmed

Proposed Revision Of Digital Rules – EU’s Good Start But Medtech Advises Caution

 

The European Commission’s Digital Omnibus Package promises to simplify EU complex digital compliance processes, but is it taking the EU in the right direction in its simplification efforts?

How The EU’s Digital Omnibus Package Could Provide Breathing Space For Medtech

 

The European Commission seems to have heeded many of the medtech industry’s points regarding challenges with the implementation of the AI Act within the Digital Omnibus. But the usual EU hurdles must be crossed before the sector will know if these proposals will make it into law.

More from Geography

interview

What Exact-ly Is In Store For Liquid Biopsy?

 

Ahead of Exact Science’s $21bn dollar acquisition by Abbott, Medtech Insight spoke to the company’s chief medical officer, Tomasz Beer, to learn more about the company’s multi-cancer early detection offering, its wider portfolio of products and to hear more about the direction of the field.

LDTs Aimed At Catching Cancers Early Hold Promise In Reducing Late-Stage Diagnoses, Study Shows

 

A recent study demonstrates that certain types of blood-based tests that screen for multiple cancers at once have the potential to flip the script on cancer diagnoses, including some of the deadliest types.

How The EU’s Digital Omnibus Package Could Provide Breathing Space For Medtech

 

The European Commission seems to have heeded many of the medtech industry’s points regarding challenges with the implementation of the AI Act within the Digital Omnibus. But the usual EU hurdles must be crossed before the sector will know if these proposals will make it into law.